新型冠状病毒肺炎疫情早期阶段阿尔茨海默病及相关痴呆的医疗保险参保者死亡率趋势
这项回顾性横断面研究基于2019年至2020年100%收费服务医疗保险A和B部分受益人数据,评估阿尔茨海默病及相关痴呆(ADRD)患者的超额死亡率。2020年调整后死亡率较2019年无ADRD者升高12.4%,ADRD患者升高25.7%,亚裔、黑人和西班牙裔ADRD患者及养老院居住者超额死亡率更高,即使在COVID-19感染率最低五分位地区仍存在超额死亡。
要点
- 2020年ADRD患者调整后死亡率较2019年升高25.7%,无ADRD者升高12.4%。
- 亚裔、黑人和西班牙裔ADRD患者超额死亡率分别为36.0%、36.7%和40.1%。
- COVID-19感染率最低五分位地区社区ADRD患者死亡率仍升高8.8%。
核心结论
- 这项横断面研究结果提示,COVID-19大流行可能与ADRD老年人超额死亡相关,尤其是亚裔、黑人和西班牙裔人群及养老院居住者,即使在COVID-19患病率低的地区也是如此。
研究设计与样本
- 回顾性横断面研究,使用2019年1月1日至2020年12月31日100%收费服务医疗保险A和B部分受益人数据,评估年龄和性别调整死亡率。
- 参与者为53 640 888名65岁及以上医疗保险参保者,分为4个预设队列:有或无ADRD的参保者,以及居住在养老院的有或无ADRD的参保者。
- 暴露为2020年1月至12月按医院转诊区划分的每月COVID-19感染率。
- 主要结局为2020年3月至12月死亡率与2019年3月至12月死亡率比较,超额死亡率通过比较2020年与2019年特定预设组死亡率计算。
- 均值比较使用t检验,95%CI使用delta法估计。
主要发现
- 2019年纳入26 952 752名医疗保险参保者,2020年纳入26 688 136名。
- 2019年社区居住无ADRD受益人平均(SD)年龄为74.1(8.8)岁,有ADRD者为82.6(8.4)岁;养老院居住有ADRD者平均(SD)年龄83.6(8.4)岁,无ADRD者为79.7(8.8)岁。
- 2019年诊断为ADRD的患者中,63.5%为女性,2.7%为亚裔,9.2%为黑人,5.7%为西班牙裔,80.7%为白人,1.7%被认定为其他(包括所有未列出的种族或族裔);2020年构成无显著变化。
- 与2019年相比,2020年调整后死亡率在无ADRD参保者中升高12.4%(95%CI,12.1%-12.6%),在所有ADRD参保者中升高25.7%(95%CI,25.3%-26.2%)。
- ADRD患者中亚裔超额死亡率为36.0%(95%CI,32.6%-39.3%),黑人为36.7%(95%CI,35.2%-38.2%),西班牙裔为40.1%(95%CI,37.9%-42.3%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The COVID-19 pandemic fundamentally altered the delivery of health care in the United States. The associations between these COVID-19-related changes and outcomes in vulnerable patients, such as among persons with Alzheimer disease and related dementias (ADRD), are not yet well understood. OBJECTIVE: To determine the association between regional rates of COVID-19 infection and excess mortality among individuals with ADRD. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cross-sectional study used data from beneficiaries of 100% fee-for-service Medicare Parts A and B between January 1, 2019, and December 31, 2020, to assess age- and sex-adjusted mortality rates. Participants were 53 640 888 Medicare enrollees 65 years of age or older categorized into 4 prespecified cohorts: enrollees with or without ADRD and enrollees with or without ADRD residing in nursing homes. EXPOSURES: Monthly COVID-19 infection rates by hospital referral region between January and December 2020. MAIN OUTCOMES AND MEASURES: Mortality rates from March through December 2020 were compared with those from March through December 2019. Excess mortality was calculated by comparing mortality rates in 2020 with rates in 2019 for specific, predetermined groups. Means were compared using t tests, and 95% CIs were estimated using the delta method. RESULTS: This cross-sectional study included 26 952 752 Medicare enrollees in 2019 and 26 688 136 enrollees in 2020. In 2019, the mean (SD) age of community-dwelling beneficiaries without ADRD was 74.1 (8.8) years and with ADRD was 82.6 (8.4) years. The mean (SD) age of nursing home residents with ADRD (83.6 [8.4] years) was similar to that for patients without ADRD (79.7 [8.8] years). Among patients diagnosed as having ADRD in 2019, 63.5% were women, 2.7% were Asian, 9.2% were Black, 5.7% were Hispanic, 80.7% were White, and 1.7% were identified as other (included all races or ethnicities other than those given); the composition did not change appreciably in 2020. Compared with 2019, adjusted mortality in 2020 was 12.4% (95% CI, 12.1%-12.6%) higher among enrollees without ADRD and 25.7% (95% CI, 25.3%-26.2%) higher among all enrollees with ADRD, with even higher percentages for Asian (36.0%; 95% CI, 32.6%-39.3%), Black (36.7%; 95% CI, 35.2%-38.2%), and Hispanic (40.1%; 95% CI, 37.9%-42.3%) populations with ADRD. The hospital referral region in the lowest quintile for COVID-19 infections in 2020 had no excess mortality among enrollees without ADRD but 8.8% (95% CI, 7.5%-10.2%) higher mortality among community-dwelling enrollees with ADRD and 14.2% (95% CI, 12.2%-16.2%) higher mortality among enrollees with ADRD living in nursing homes. CONCLUSIONS AND RELEVANCE: The results of this cross-sectional study suggest that the COVID-19 pandemic may be associated with excess mortality among older adults with ADRD, especially for Asian, Black, and Hispanic populations and people living in nursing homes, even in areas with low COVID-19 prevalence.
引用
- Gilstrap L, Zhou W, Alsan M, et al. Trends in Mortality Rates Among Medicare Enrollees With Alzheimer Disease and Related Dementias Before and During the Early Phase of the COVID-19 Pandemic. JAMA Neurol. 2022. PMID: 35226041. doi:10.1001/jamaneurol.2022.0010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。